Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1982;2:58-67

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zumoff, B.
Right arrow Articles by Fukushima, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zumoff, B.
Right arrow Articles by Fukushima, D. K.

Arteriosclerosis, Vol 2, 58-67, Copyright © 1982 by American Heart Association


ARTICLES

Abnormal hormone levels in men with coronary artery disease

B Zumoff, RG Troxler, J O'Connor, RS Rosenfeld, J Kream, J Levin, JR Hickman, AM Sloan, W Walker, RL Cook and DK Fukushima

Plasma concentrations and urinary excretions of various hormones and hormone metabolites were measured in four groups. Group 1 was composed of 13 men with prior myocardial infarction; Group 2 contained 35 clinically normal men; Group 3 consisted of 44 men with normal coronary arteriograms; and Group 4 was composed of 25 men with severe coronary artery disease shown on arteriogram but no infarction. There were four major findings: Group 1 had significantly higher 24-hour mean plasma concentrations of estrone (E1), dehydroisoandrosterone (DHA), and dehydroisoandrosterone sulfate (DHAS) than Group 2, while Group 3 had the same levels as Group 4; Group 4 had significantly lower urinary excretion of androsterone glucuronide (AG) than Group 3, while Group 1 excreted normal amounts. There are three possible explanations for these findings: 1) myocardial infarction occurring in men with coronary artery disease may elevate the plasma levels of E1, DHA, and DHAS and eliminate the preinfarction depression of urinary AG levels; 2) higher than average levels of E1, DHA, DHAS, and AG may favor the development of infarction in men with coronary artery disease; 3) higher than average levels of E1, DHA, DHAS, and AG may favor survival from any infarction that occurs in men with coronary artery disease. Experimental and epidemiological evidence seems to favor the third possibility.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
K. H. Mikulec, L. Holloway, R. E. Krasnow, H. Javitz, G. E. Swan, T. Reed, R. Marcus, and D. Carmelli
Relationship of Endogenous Sex Hormones to Coronary Heart Disease: A Twin Study
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1240 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee
Endogenous Sex Hormones and Cardiovascular Disease in Men
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
F. C. W. Wu and A. von Eckardstein
Androgens and Coronary Artery Disease
Endocr. Rev., April 1, 2003; 24(2): 183 - 217.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
H. A. Feldman, C. B. Johannes, A. B. Araujo, B. A. Mohr, C. Longcope, and J. B. McKinlay
Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-aged Men: Prospective Results from the Massachusetts Male Aging Study
Am. J. Epidemiol., January 1, 2001; 153(1): 79 - 89.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kiechl, J. Willeit, E. Bonora, S. Schwarz, and Q. Xu
No Association Between Dehydroepiandrosterone Sulfate and Development of Atherosclerosis in a Prospective Population Study (Bruneck Study)
Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1094 - 1100.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
E. Barrett-Connor and D. Goodman-Gruen
Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women
BMJ, November 4, 1995; 311(7014): 1193 - 1196.
[Abstract] [Full Text]